Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

339 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Long-term outcome of Crohn's disease patients with upper gastrointestinal stricture: A GETAID study.
Lambin T, Amiot A, Stefanescu C, Gornet JM, Seksik P, Laharie D, Reenaers C, Bourreille A, Cadiot G, Carbonnel F, Dib N, Fumery M, Gilletta de St Joseph C, Filippi J, Viennot S, Plastaras L, Coffin B, Serrero M, Nahon S, Pineton de Chambrun G, Rahier JF, Roblin X, Boualit M, Bouguen G, Peyrin-Biroulet L, Pariente B; UGT-CD-stricture GETAID study group. Lambin T, et al. Among authors: roblin x. Dig Liver Dis. 2020 Nov;52(11):1323-1330. doi: 10.1016/j.dld.2020.08.034. Epub 2020 Sep 20. Dig Liver Dis. 2020. PMID: 32962965 Free article.
Multidrug resistance gene-1 polymorphisms and resistance to cyclosporine A in patients with steroid resistant ulcerative colitis.
Daniel F, Loriot MA, Seksik P, Cosnes J, Gornet JM, Lémann M, Fein F, Vernier-Massouille G, De Vos M, Boureille A, Treton X, Flourié B, Roblin X, Louis E, Zerbib F, Beaune P, Marteau P. Daniel F, et al. Among authors: roblin x. Inflamm Bowel Dis. 2007 Jan;13(1):19-23. doi: 10.1002/ibd.20046. Inflamm Bowel Dis. 2007. PMID: 17206635 Free article.
Coffee and diabetes: is homocysteine the missing link?
Peyrin-Biroulet L, Guéant JL, Roblin X. Peyrin-Biroulet L, et al. Among authors: roblin x. Arch Intern Med. 2007 Jan 22;167(2):204; author reply 205. doi: 10.1001/archinte.167.2.204-a. Arch Intern Med. 2007. PMID: 17242324 No abstract available.
Long-term outcome of adalimumab therapy for ulcerative colitis with intolerance or lost response to infliximab: a single-centre experience.
Oussalah A, Laclotte C, Chevaux JB, Bensenane M, Babouri A, Serre AA, Boucekkine T, Roblin X, Bigard MA, Peyrin-Biroulet L. Oussalah A, et al. Among authors: roblin x. Aliment Pharmacol Ther. 2008 Oct 15;28(8):966-72. doi: 10.1111/j.1365-2036.2008.03811.x. Epub 2008 Jul 24. Aliment Pharmacol Ther. 2008. PMID: 18652603 Free article. Clinical Trial.
Infliximab for refractory ulcerative proctitis.
Bouguen G, Roblin X, Bourreille A, Feier L, Filippi J, Nancey S, Bretagne JF, Flourié B, Hébuterne X, Bigard MA, Siproudhis L, Peyrin-Biroulet L. Bouguen G, et al. Among authors: roblin x. Aliment Pharmacol Ther. 2010 Jun;31(11):1178-85. doi: 10.1111/j.1365-2036.2010.04293.x. Epub 2010 Mar 8. Aliment Pharmacol Ther. 2010. PMID: 20222911 Free article.
A multicenter experience with infliximab for ulcerative colitis: outcomes and predictors of response, optimization, colectomy, and hospitalization.
Oussalah A, Evesque L, Laharie D, Roblin X, Boschetti G, Nancey S, Filippi J, Flourié B, Hebuterne X, Bigard MA, Peyrin-Biroulet L. Oussalah A, et al. Among authors: roblin x. Am J Gastroenterol. 2010 Dec;105(12):2617-25. doi: 10.1038/ajg.2010.345. Epub 2010 Aug 24. Am J Gastroenterol. 2010. PMID: 20736936
339 results